| 2023 | Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome
| EUROPACE |
| 2013 | Late respiratory infection after lung transplantation
| TUBERCULOSIS AND RESPIRATORY DISEASES |
| 2013 | Late stent malapposition combined by thrombus resolution after primary stenting in acute myocardial infarction: optical coherence tomography findings.
| Anadolu Kardiyoloji Dergisi |
| 2011 | Late stent thrombosis after drug-eluting stent implantation: a rare case of accelerated neo-atherosclerosis and early manifestation of neointimal rupture.
| KOREAN CIRCULATION JOURNAL |
| 2016 | Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction (APPOSITION-AMI). | EUROINTERVENTION |
| 2010 | Late-onset congestive heart failure in a patient with a 58-year-old huge traumatic carotid-jugular fistula and pseudoaneurysm: endovascular treatment with a stent-graft. | ANNALS OF VASCULAR SURGERY |
| 2012 | Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure.
| DIABETES & METABOLISM JOURNAL |
| 2019 | Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study | LANCET ONCOLOGY |
| 2023 | Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study | LUNG CANCER |
| 2023 | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301 | JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
| JOURNAL OF THORACIC ONCOLOGY |
| 2022 | Lazertinib: on the Way to Its Throne
| YONSEI MEDICAL JOURNAL |
| 2019 | LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study | ANNALS OF ONCOLOGY |
| 2019 | LBA4 - Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the Phase 3 MYSTIC study | ANNALS OF ONCOLOGY |
| 2022 | LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) | ANNALS OF ONCOLOGY |
| 2021 | LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis | EXPERT OPINION ON BIOLOGICAL THERAPY |
| 2014 | LDL Cholesterol Affects Clinical Outcomes in Incident Hemodialysis Patients During the Early Stages of Dialysis | BLOOD PURIFICATION |
| 1999 | LDL-콜레스테롤 상승 환자에 대한 Atorva-statin의
유효성 및 안전성에 대한 연구
| Korean Circulation Journal (순환기) |
| 2023 | Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean?
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Learnability of Thyroid Nodule Assessment on Ultrasonography: Using a Big Data Set | ULTRASOUND IN MEDICINE AND BIOLOGY |
